MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

January 19, 2017

NEW YORK, JANUARY 20, 2017—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) began a new clinical trial this week in Uzbekistan to develop a radically improved course of treatment for drug-resistant tuberculosis (DR-TB).

The trial aims to find a treatment regimen for DR-TB that is drastically shorter, more effective, and causes fewer side effects than the current treatment options.

May 12, 2016

The World Health Organization has just recommended that countries move toward shorter treatment regimens for some people with drug-resistant tuberculosis (DR-TB), including people co-infected with HIV, children, and people with simple MDR-TB who have not been treated before or and have no known resistance to any of the drugs in the regimen. This recommendation comes following results from a number of large observation cohort studies using the shortened regimen.

October 14, 2015

Alhassane Zaharia, Benin - 17 years old

"In school in Benin we learned about the map of the world: Africa, Asia, Europe, America. But how could we know that Italy was so far away? In Libya they lied to us. They said Italy is seven hours away from the Libyan shore. We had no choice but to believe them.

August 06, 2015

In Uzbekistan’s Autonomous Republic of Karakalpakstan, Doctors Without Borders/Médecins Sans Frontières (MSF) runs a tuberculosis (TB) program in collaboration with the Ministry of Health, helping patients manage the side effects of their drug regimens and providing psychosocial support to improve treatment adherence. Here, MSF medical team leader Tetyana Pylypenko discusses MSF’s

December 17, 2013

Tuberculosis (TB) and its drug-resistant forms are a global health threat to which children are particularly vulnerable.

July 11, 2013

MSF doctor Emily Wise blogs from Karakalpakstan, Uzbekistan, where MSF is working to treat tuberculosis patients.

October 12, 2012

Twenty-six years after first working in the country in 1986, Doctors Without Borders/Médecins Sans Frontières (MSF) teams have handed over the last remaining projects in Sri Lanka and MSF has left the country.

October 12, 2012

This month, we visit the Ubangi river, where MSF is treating yaws among the Pygmy population; Niger, where the rainy season and food insecurity have exacerbated malaria and malnutrition; and Sri Lanka, where after 32 years MSF is handing over its last remaining project and leaving the country. Additionally, learn about the court case Swiss pharmaceutical company Novartis has brought against India, the "pharmacy of the developing world."

October 03, 2012

In August 2012, MSF handed over its last remaining project in Sri Lanka to World Vision, an established international NGO with a long-term operational plan for the north of the country. 

April 05, 2012

In northwestern Uzbekistan, drug-resistant forms of tuberculosis (TB) are spreading while only one in 10 people with TB receives treatment. Doctors Without Borders/Médecins Sans Frontières (MSF) has treated more than 2,000 people with drug-resistant TB in Uzbekistan over the last 10 years.

Pages

January 19, 2017

NEW YORK, JANUARY 20, 2017—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) began a new clinical trial this week in Uzbekistan to develop a radically improved course of treatment for drug-resistant tuberculosis (DR-TB).

The trial aims to find a treatment regimen for DR-TB that is drastically shorter, more effective, and causes fewer side effects than the current treatment options.

May 12, 2016

The World Health Organization has just recommended that countries move toward shorter treatment regimens for some people with drug-resistant tuberculosis (DR-TB), including people co-infected with HIV, children, and people with simple MDR-TB who have not been treated before or and have no known resistance to any of the drugs in the regimen. This recommendation comes following results from a number of large observation cohort studies using the shortened regimen.

October 14, 2015

Alhassane Zaharia, Benin - 17 years old

"In school in Benin we learned about the map of the world: Africa, Asia, Europe, America. But how could we know that Italy was so far away? In Libya they lied to us. They said Italy is seven hours away from the Libyan shore. We had no choice but to believe them.

August 06, 2015

In Uzbekistan’s Autonomous Republic of Karakalpakstan, Doctors Without Borders/Médecins Sans Frontières (MSF) runs a tuberculosis (TB) program in collaboration with the Ministry of Health, helping patients manage the side effects of their drug regimens and providing psychosocial support to improve treatment adherence. Here, MSF medical team leader Tetyana Pylypenko discusses MSF’s

December 17, 2013

Tuberculosis (TB) and its drug-resistant forms are a global health threat to which children are particularly vulnerable.

July 11, 2013

MSF doctor Emily Wise blogs from Karakalpakstan, Uzbekistan, where MSF is working to treat tuberculosis patients.

October 12, 2012

Twenty-six years after first working in the country in 1986, Doctors Without Borders/Médecins Sans Frontières (MSF) teams have handed over the last remaining projects in Sri Lanka and MSF has left the country.

October 12, 2012

This month, we visit the Ubangi river, where MSF is treating yaws among the Pygmy population; Niger, where the rainy season and food insecurity have exacerbated malaria and malnutrition; and Sri Lanka, where after 32 years MSF is handing over its last remaining project and leaving the country. Additionally, learn about the court case Swiss pharmaceutical company Novartis has brought against India, the "pharmacy of the developing world."

October 03, 2012

In August 2012, MSF handed over its last remaining project in Sri Lanka to World Vision, an established international NGO with a long-term operational plan for the north of the country. 

April 05, 2012

In northwestern Uzbekistan, drug-resistant forms of tuberculosis (TB) are spreading while only one in 10 people with TB receives treatment. Doctors Without Borders/Médecins Sans Frontières (MSF) has treated more than 2,000 people with drug-resistant TB in Uzbekistan over the last 10 years.

Pages